Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate.

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2001
This article has no abstract
Epistemonikos ID: e56a0122658c4bca580c11e4f929dfe49be5758a
First added on: Apr 03, 2025